Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Preventive prophylactic treatment in posttraumatic epilepsy].

A Oliveros-Juste1, V Bertol, A Oliveros-Cid

  • 1Servicio de Neurología, Policlinica Sagasta, Zaragoza, 50006, Espańa. aoliveros@hmservet.insalud.es

Revista De Neurologia
|June 1, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[OnabotulinumtoxinA in the treatment of atypical odontalgia: description of a clinical case].

Anales del sistema sanitario de Navarra·2019
Same author

Practical application of brief cognitive tests.

Neurologia (Barcelona, Spain)·2015
Same author

[Quality as management tool. Actions to improve efficiency in neurological care].

Neurologia (Barcelona, Spain)·2009
Same author

[Importance and factors related to chronic fatigue in multiple sclerosis].

Neurologia (Barcelona, Spain)·2005
Same author

[Sleep disorders in multiple sclerosis].

Neurologia (Barcelona, Spain)·2004
Same author

[Predicting factors for depression in multiple sclerosis].

Neurologia (Barcelona, Spain)·2004

Posttraumatic epilepsy (PTE) affects 2-3% of epilepsy cases. Current antiepileptic drugs show limited prophylactic efficacy for PTE, necessitating research into novel treatments like neuroprotectors and receptor blockers.

Area of Science:

  • Neurology
  • Neuroscience
  • Epileptology

Context:

  • Posttraumatic epilepsy (PTE) arises from traumatic brain injury (TBI).
  • Early seizures post-TBI, while not strictly epileptic, are risk factors for developing PTE.
  • PTE affects 5-20% of TBI patients, particularly those with severe injuries.

Purpose:

  • To evaluate the prophylactic efficacy of antiepileptic drugs (AEDs) for PTE.
  • To explore novel therapeutic targets beyond traditional AEDs for PTE prevention.
  • To recommend a risk-factor-based strategy for PTE management.

Summary:

  • Classic AEDs (Phenobarbital, Phenytoin, Carbamazepine, Valproate) lack confirmed prophylactic efficacy against the 'kindling' effect in PTE.
  • Emerging strategies involve lipid peroxidation inhibitors, neuroprotectors (antioxidants), glutamic and NMDA receptor blockers, and apoptosis modulators.

Related Experiment Videos

  • A tailored approach, considering individual risk factors and focusing on AEDs with proven partial seizure efficacy and good tolerability, is advised.

    • Impact:

    • Highlights the limitations of current AEDs in PTE prophylaxis.
    • Identifies promising new drug classes for future PTE therapeutic development.
    • Advocates for personalized medicine in managing PTE risk and treatment.